PL428257A1 - Wyizolowany szczep bakterii Mycoplasma bovis i szczepionka zawierająca szczep bakterii Mycoplasma bovis - Google Patents

Wyizolowany szczep bakterii Mycoplasma bovis i szczepionka zawierająca szczep bakterii Mycoplasma bovis

Info

Publication number
PL428257A1
PL428257A1 PL428257A PL42825718A PL428257A1 PL 428257 A1 PL428257 A1 PL 428257A1 PL 428257 A PL428257 A PL 428257A PL 42825718 A PL42825718 A PL 42825718A PL 428257 A1 PL428257 A1 PL 428257A1
Authority
PL
Poland
Prior art keywords
bacterial strain
mycoplasma bovis
bovis bacterial
vaccine
isolated
Prior art date
Application number
PL428257A
Other languages
English (en)
Other versions
PL236776B1 (pl
Inventor
Katarzyna Dudek
Ewelina Szacawa
Dariusz Bednarek
Original Assignee
Państwowy Instytut Weterynaryjny-Państwowy Instytut Badawczy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Państwowy Instytut Weterynaryjny-Państwowy Instytut Badawczy filed Critical Państwowy Instytut Weterynaryjny-Państwowy Instytut Badawczy
Priority to PL428257A priority Critical patent/PL236776B1/pl
Publication of PL428257A1 publication Critical patent/PL428257A1/pl
Publication of PL236776B1 publication Critical patent/PL236776B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Przedmiotem zgłoszenia jest szczep bakterii Mycoplasma bovis MbPL01 zdeponowany, pod numerem B/00172 oraz szczepionka, której głównym składnikiem jest inaktywowany szczep Mycoplasma bovis MbPL01, zdeponowany pod numerem B/00172.
PL428257A 2018-12-19 2018-12-19 Wyizolowany szczep bakterii Mycoplasma bovis i szczepionka zawierająca szczep bakterii Mycoplasma bovis PL236776B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL428257A PL236776B1 (pl) 2018-12-19 2018-12-19 Wyizolowany szczep bakterii Mycoplasma bovis i szczepionka zawierająca szczep bakterii Mycoplasma bovis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL428257A PL236776B1 (pl) 2018-12-19 2018-12-19 Wyizolowany szczep bakterii Mycoplasma bovis i szczepionka zawierająca szczep bakterii Mycoplasma bovis

Publications (2)

Publication Number Publication Date
PL428257A1 true PL428257A1 (pl) 2020-03-09
PL236776B1 PL236776B1 (pl) 2021-02-22

Family

ID=69709551

Family Applications (1)

Application Number Title Priority Date Filing Date
PL428257A PL236776B1 (pl) 2018-12-19 2018-12-19 Wyizolowany szczep bakterii Mycoplasma bovis i szczepionka zawierająca szczep bakterii Mycoplasma bovis

Country Status (1)

Country Link
PL (1) PL236776B1 (pl)

Also Published As

Publication number Publication date
PL236776B1 (pl) 2021-02-22

Similar Documents

Publication Publication Date Title
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
CL2018002198A1 (es) Mezclas y composiciones que comprenden cepas de paenibacillus o metabolitos de estas y otros bioplaguicidas
CY1125211T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
MX2021006564A (es) Sistemas activos dinamicos acromosomicos.
PH12020551716A1 (en) Anti-ror antibody constructs
MA55364A (fr) Bioconjugués d'antigènes polysaccharidiques o d'e. coli, procédés de production de ces derniers, et méthodes d'utilisation de ces derniers
PH12020550904A1 (en) Immunostimulatory oligonucleotides
SG11202000123SA (en) Lactobacillus plantarum cjlp475 strain having antiviral and immunomodulatory effects and composition comprising the same
MY194449A (en) Zika vaccines and immunogenic compositions, and methods of using the same
CO2021000092A2 (es) Anticuerpos que comprenden un polipéptido insertado en la región 3 del marco
MX378890B (es) Bifidobacterium longum ncimb 41715 para usarse en el tratamiento de obesidad y trastornos metabólicos asociados.
MX2021009105A (es) Toxinas apxia, apxiia y apxiiia inactivadas.
EP3880828A4 (en) PLANT VECTORS, COMPOSITIONS AND USES RELATED THERETO
DK3755347T3 (da) Universelle antigenpræsenterende celler og anvendelser deraf
MX390729B (es) Composiciones y usos de bacillus
PH12021550175A1 (en) Composition containing influenza vaccine
BR112022009721A2 (pt) Dispositivos de anel intravaginal
WO2018135843A3 (ko) 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 락토바실러스 퍼멘텀 균주 및 이를 포함하는 조성물
MX392976B (es) Composiciones que comprenden cepas bacterianas.
EA202190876A1 (ru) Композиции, содержащие бактериальные штаммы
SG10201806014TA (en) Feedback canceller and hearing aid
CL2022001509A1 (es) Vacuna inactivada contra el ortoreovirus de los peces.
MY191299A (en) String set, main string, and cross string
CO2018009535A1 (es) Cables flexibles libres halógenos de baja emisión de humo
JOP20200108B1 (ar) تركيبات تشتمل على مستخلص دهون بلح البحر وزيت الكريل , وتطبيقاتها الطبية